Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Accenture
Queensland Health
Novartis
AstraZeneca
Boehringer Ingelheim
Medtronic
Cipla
Cerilliant

Generated: February 19, 2018

DrugPatentWatch Database Preview

Naratriptan hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for naratriptan hydrochloride and what is the scope of naratriptan hydrochloride freedom to operate?

Naratriptan hydrochloride
is the generic ingredient in two branded drugs marketed by Glaxosmithkline Llc, Apotex Corp, Heritage Pharms Inc, Mylan Pharms Inc, Orchid Hlthcare, Paddock Llc, Sandoz, Sun Pharm Inds Ltd, Teva Pharms, and West-ward Pharms Int, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for naratriptan hydrochloride. Six suppliers are listed for this compound.
Pharmacology for naratriptan hydrochloride

US Patents and Regulatory Information for naratriptan hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 202431-002 May 31, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 090381-002 Jul 7, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Orchid Hlthcare NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 091441-001 Apr 30, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Paddock Llc NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 091326-002 Jul 8, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex Corp NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 091373-001 Apr 22, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 078751-001 Jul 7, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Orchid Hlthcare NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 091441-002 Apr 30, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc AMERGE naratriptan hydrochloride TABLET;ORAL 020763-002 Feb 10, 1998 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Paddock Llc NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 091326-001 Jul 8, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 090288-002 Jul 7, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for naratriptan hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Llc AMERGE naratriptan hydrochloride TABLET;ORAL 020763-002 Feb 10, 1998 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc AMERGE naratriptan hydrochloride TABLET;ORAL 020763-001 Feb 10, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Merck
Medtronic
US Army
Boehringer Ingelheim
Deloitte
Farmers Insurance
Covington
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot